Terms: = Germ cell tumor AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16
78 results:
1. Value of long non-coding RNA HAS2-AS1 as a diagnostic and prognostic marker of glioma.
You A; Gu J; Wang J; Li J; Zhang Y; Rao G; Ge X; Zhang K; Gao X; Wang D
Neurologia (Engl Ed); 2024 May; 39(4):353-360. PubMed ID: 38616063
[TBL] [Abstract] [Full Text] [Related]
2. Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus.
Li Z; Lei Z; Yang W; Jing C; Sun X; Yang G; Zhao X; Zhang M; Xu M; Tang Y; Wang Q; Zhao J; Zhou Z; Wen Z; Chen X; Peng Q; Wang G; Zhang P; Sun E; Shen N; Xu W; Li Z; Yang H; Yin Z
Parasit Vectors; 2024 Jan; 17(1):44. PubMed ID: 38291478
[TBL] [Abstract] [Full Text] [Related]
3. Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature.
Mulders MCF; Audhoe AS; Van Koetsveld PM; Feelders RA; Hofland LJ; de Herder WW; Kraaij R; Hofland J
Eur J Cancer; 2024 Jan; 197():113472. PubMed ID: 38100919
[TBL] [Abstract] [Full Text] [Related]
4. Association of early surgery and absence of ataxia with full recovery after spinal intramedullary ependymoma resection.
Alhalabi OT; Heene S; Landré V; Neumann JO; Haux D; Zweckberger K; Unterberg AW; Younsi A
J Neurosurg Spine; 2024 Feb; 40(2):185-195. PubMed ID: 37922542
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed germ cell tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract] [Full Text] [Related]
6. Increased confidence of radiomics facilitating pretherapeutic differentiation of BRAF-altered pediatric low-grade glioma.
Kudus K; Wagner MW; Namdar K; Nobre L; Bouffet E; Tabori U; Hawkins C; Yeom KW; Ertl-Wagner BB; Khalvati F
Eur Radiol; 2024 Apr; 34(4):2772-2781. PubMed ID: 37803212
[TBL] [Abstract] [Full Text] [Related]
7. Identification of an Ultra-High-Risk Subgroup of Neuroblastoma Patients within the High-Risk Cohort Using a Computed Tomography-Based Radiomics Approach.
Wang H; Chen X; Li T; Xie M; Qin J; Zhang L; Ding H; He L
Acad Radiol; 2024 Apr; 31(4):1655-1665. PubMed ID: 37714717
[TBL] [Abstract] [Full Text] [Related]
8. Marital Status Independently Predicts Mortality in Adult Patients with Craniopharyngioma: A SEER-Based Study.
Pham J; Rhee B; Malpass R; Ozcan EE; Shaaya E; Doberstein C; Toms S; Sullivan P
World Neurosurg; 2023 Jul; 175():e367-e379. PubMed ID: 37003530
[TBL] [Abstract] [Full Text] [Related]
9. Recurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.
Montgomery EY; Thirunavu V; Pagadala M; Shlobin NA; Plant-Fox AS; Lam S; DeCuypere M
J Neurosurg Pediatr; 2023 Feb; 31(2):132-142. PubMed ID: 36433871
[TBL] [Abstract] [Full Text] [Related]
10. Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
Ferrazzoli V; Shankar A; Cockle JV; Tang C; Al-Khayfawee A; Bomanji J; Fraioli F; Hyare H
Nucl Med Commun; 2023 Jan; 44(1):91-99. PubMed ID: 36378239
[TBL] [Abstract] [Full Text] [Related]
11. Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Hendrikse LD; Haldipur P; Saulnier O; Millman J; Sjoboen AH; Erickson AW; Ong W; Gordon V; Coudière-Morrison L; Mercier AL; Shokouhian M; Suárez RA; Ly M; Borlase S; Scott DS; Vladoiu MC; Farooq H; Sirbu O; Nakashima T; Nambu S; Funakoshi Y; Bahcheli A; Diaz-Mejia JJ; Golser J; Bach K; Phuong-Bao T; Skowron P; Wang EY; Kumar SA; Balin P; Visvanathan A; Lee JJY; Ayoub R; Chen X; Chen X; Mungall KL; Luu B; Bérubé P; Wang YC; Pfister SM; Kim SK; Delattre O; Bourdeaut F; Doz F; Masliah-Planchon J; Grajkowska WA; Loukides J; Dirks P; Fèvre-Montange M; Jouvet A; French PJ; Kros JM; Zitterbart K; Bailey SD; Eberhart CG; Rao AAN; Giannini C; Olson JM; Garami M; Hauser P; Phillips JJ; Ra YS; de Torres C; Mora J; Li KKW; Ng HK; Poon WS; Pollack IF; López-Aguilar E; Gillespie GY; Van Meter TE; Shofuda T; Vibhakar R; Thompson RC; Cooper MK; Rubin JB; Kumabe T; Jung S; Lach B; Iolascon A; Ferrucci V; de Antonellis P; Zollo M; Cinalli G; Robinson S; Stearns DS; Van Meir EG; Porrati P; Finocchiaro G; Massimino M; Carlotti CG; Faria CC; Roussel MF; Boop F; Chan JA; Aldinger KA; Razavi F; Silvestri E; McLendon RE; Thompson EM; Ansari M; Garre ML; Chico F; Eguía P; Pérezpeña M; Morrissy AS; Cavalli FMG; Wu X; Daniels C; Rich JN; Jones SJM; Moore RA; Marra MA; Huang X; Reimand J; Sorensen PH; Wechsler-Reya RJ; Weiss WA; Pugh TJ; Garzia L; Kleinman CL; Stein LD; Jabado N; Malkin D; Ayrault O; Golden JA; Ellison DW; Doble B; Ramaswamy V; Werbowetski-Ogilvie TE; Suzuki H; Millen KJ; Taylor MD
Nature; 2022 Sep; 609(7929):1021-1028. PubMed ID: 36131014
[TBL] [Abstract] [Full Text] [Related]
12. RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma.
Mladek AC; Yan H; Tian S; Decker PA; Burgenske DM; Bakken K; Hu Z; He L; Connors MA; Carlson BL; Wilson J; Bommi-Reddy A; Conery A; Eckel-Passow JE; Sarkaria JN; Kitange GJ
Neuro Oncol; 2022 Aug; 24(8):1261-1272. PubMed ID: 35231103
[TBL] [Abstract] [Full Text] [Related]
13. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.
Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y
Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485
[TBL] [Abstract] [Full Text] [Related]
14. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
[No Abstract] [Full Text] [Related]
15. Survival and medical costs of melanoma patients with subsequent cancer diagnoses: A South Korean population-based retrospective cohort study.
Park HY; Yang HJ; Jeon SM; Lee IH; Kwon JW
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e211-e219. PubMed ID: 34166566
[TBL] [Abstract] [Full Text] [Related]
16. Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients.
Mojtahed SA; Boyer NR; Rao SA; Gajewski TF; Tseng J; Turaga KK
Ann Surg Oncol; 2021 Dec; 28(13):9039-9047. PubMed ID: 34129153
[TBL] [Abstract] [Full Text] [Related]
17. A hybrid feature selection-based brain tumor detection and segmentation in multiparametric magnetic resonance imaging.
Chen H; Ban D; Qi XS; Pan X; Qiang Y; Yang Q
Med Phys; 2021 Nov; 48(11):7360-7371. PubMed ID: 34101842
[TBL] [Abstract] [Full Text] [Related]
18. A hybrid feature selection-based approach for brain tumor detection and automatic segmentation on multiparametric magnetic resonance images.
Chen H; Ban D; Qi XS; Pan X; Qiang Y; Yang Q
Med Phys; 2021 Nov; 48(11):6614-6626. PubMed ID: 34089524
[TBL] [Abstract] [Full Text] [Related]
19. MRI Features May Predict Molecular Features of Glioblastoma in
Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
[TBL] [Abstract] [Full Text] [Related]
20. Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine tumors.
Li Y; Fan G; Yu F; Tian C; Tan H
Neuroendocrinology; 2021; 111(12):1231-1237. PubMed ID: 33370727
[TBL] [Abstract] [Full Text] [Related]
[Next]
